Most Recent

image: Year of the Fetus

Year of the Fetus

By | December 18, 2012

2012 saw the birth of a handful of non-invasive genetic prenatal tests, but the young industry faces growing pains as legal and ethical questions loom. 

2 Comments

image: 2012 Multimedia Roundup

2012 Multimedia Roundup

By | December 14, 2012

The science images and videos that captured our attention in 2012

1 Comment

image: Single Patent for EU

Single Patent for EU

By | December 12, 2012

After decades of political wrangling, the European Union is poised to introduce a single patent system to reduce red tape and application costs for researchers and companies.

1 Comment

image: Maggot Medicine

Maggot Medicine

By | December 10, 2012

The healing powers of maggots may lie in their secreted proteins, which restrain the human immune response.

2 Comments

image: Drug Approvals Up

Drug Approvals Up

By | December 7, 2012

The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.  

0 Comments

image: Opinion: Parachuting off the Patent Cliff

Opinion: Parachuting off the Patent Cliff

By | December 6, 2012

As the United States edges ever closer to the dreaded fiscal cliff, the pharmaceutical industry approaches a precipice of its own.

4 Comments

image: Hurry Up, FDA

Hurry Up, FDA

By | December 6, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: MicroRNAs Repair Heart Cells

MicroRNAs Repair Heart Cells

By | December 5, 2012

Researchers identify microRNAs that keep cardiac cells healthy after heart attack, potentially paving the way for future heart regenerating therapies.

1 Comment

image: New Mental Health Manual

New Mental Health Manual

By | December 5, 2012

Amid controversy, the American Psychiatric Association has approved the fifth edition of its guidebook on mental disorders.

1 Comment

image: Special Review for H5N1 Grants?

Special Review for H5N1 Grants?

By | December 4, 2012

The National Institutes of Health reveals a controversial plan to regulate the funding of H5N1 research.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech